Lexagene Holdings Financials

LXXGFDelisted Stock  USD 0.08  0.00  0.00%   
Based on the key indicators related to Lexagene Holdings' liquidity, profitability, solvency, and operating efficiency, Lexagene Holdings is not in a good financial situation at the moment. It has a very high risk of going through financial straits in July.
With this module, you can analyze Lexagene financials for your investing period. You should be able to track the changes in Lexagene Holdings individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Lexagene Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lexagene Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in Lexagene Holdings' assets may result in an increase in income on the income statement.
The data published in Lexagene Holdings' official financial statements typically reflect Lexagene Holdings' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Lexagene Holdings' quantitative information. For example, before you start analyzing numbers published by Lexagene accountants, it's essential to understand Lexagene Holdings' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the presentation of Lexagene Holdings' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lexagene Holdings' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Lexagene Holdings' management manipulating its earnings.

Lexagene Holdings Stock Summary

Lexagene Holdings competes with CanSino Biologics, Azul SA, Monster Beverage, Willamette Valley, and Diageo PLC. LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts. Lexagene Holdings operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 33 people.
InstrumentUSA OTC Stock View All
ExchangeOTCQB Exchange
ISINCA52886L1031
Business Address500 Cummings Center,
SectorHealthcare
IndustryMedical Devices
BenchmarkNYSE Composite
Websitewww.lexagene.com
Phone800 215 1824
CurrencyUSD - US Dollar

Lexagene Holdings Key Financial Ratios

There are many critical financial ratios that Lexagene Holdings' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lexagene Holdings reports annually and quarterly.

Lexagene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lexagene Holdings's current stock value. Our valuation model uses many indicators to compare Lexagene Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lexagene Holdings competition to find correlations between indicators driving Lexagene Holdings's intrinsic value. More Info.
Lexagene Holdings is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lexagene Holdings' earnings, one of the primary drivers of an investment's value.

Lexagene Holdings Market Pulse

 Quote0.0806
 Change(%) 0.00  
 Change0.00 
 Open0.0806
 Low0.0806
 High0.0806
 Volume0
 ExchangeOTCQB
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Note that the Lexagene Holdings information on this page should be used as a complementary analysis to other Lexagene Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Consideration for investing in Lexagene OTC Stock

If you are still planning to invest in Lexagene Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexagene Holdings' history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity